Humana Inc (NYSE: HUM) on Tuesday, plunged -2.82% from the previous trading day, before settling in for the closing price of $304.18. Within the past 52 weeks, HUM’s price has moved between $213.31 and $527.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 13.38%. The company achieved an average annual earnings per share of -38.10%. With a float of $120.15 million, this company’s outstanding shares have now reached $122.22 million.
Let’s determine the extent of company efficiency that accounts for 67600 employees. In terms of profitability, gross margin is 88.39%, operating margin of 2.28%, and the pretax margin is 1.73%.
Humana Inc (HUM) Breakdown of a Key Holders of the stock
Observing investor behavior towards Healthcare Plans industry stocks is more important than anything else. The insider ownership of Humana Inc is 0.22%, while institutional ownership is 94.29%. The most recent insider transaction that took place on Feb 20 ’24, was worth 200,066. In this transaction Director of this company bought 545 shares at a rate of $367.09, taking the stock ownership to the 2,578 shares.
Humana Inc (HUM) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -38.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.51% during the next five years compared to 10.46% growth over the previous five years of trading.
Humana Inc (NYSE: HUM) Trading Performance Indicators
Humana Inc (HUM) is currently performing well based on its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.29, a number that is poised to hit -2.08 in the next quarter and is forecasted to reach 17.16 in one year’s time.
Technical Analysis of Humana Inc (HUM)
Looking closely at Humana Inc (NYSE: HUM), its last 5-days average volume was 1.83 million, which is a drop from its year-to-date volume of 1.87 million. As of the previous 9 days, the stock’s Stochastic %D was 75.65%. Additionally, its Average True Range was 11.34.
During the past 100 days, Humana Inc’s (HUM) raw stochastic average was set at 42.60%, which indicates a significant decrease from 60.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.04% in the past 14 days, which was lower than the 47.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $276.26, while its 200-day Moving Average is $331.57. However, in the short run, Humana Inc’s stock first resistance to watch stands at $301.57. Second resistance stands at $307.55. The third major resistance level sits at $311.10. If the price goes on to break the first support level at $292.04, it is likely to go to the next support level at $288.49. Now, if the price goes above the second support level, the third support stands at $282.51.
Humana Inc (NYSE: HUM) Key Stats
Market capitalization of the company is 35.59 billion based on 120,411K outstanding shares. Right now, sales total 106,374 M and income totals 2,489 M. The company made 29,397 M in profit during its latest quarter, and 480,000 K in sales during its previous quarter.
